# The Potential of Patient-reported Outcome Measures in Detection of Relapse in Diffuse Large B-cell Lymphoma

> **NCT04695366** · — · COMPLETED · sponsor: **Herlev Hospital** · enrollment: 250 (actual)

## Conditions studied

- Diffuse Large B Cell Lymphoma
- Patient Reported Outcome

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT04695366
- **Lead sponsor:** Herlev Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-10
- **Primary completion:** 2023-04-30
- **Final completion:** 2023-04-30
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2024-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04695366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04695366, "The Potential of Patient-reported Outcome Measures in Detection of Relapse in Diffuse Large B-cell Lymphoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04695366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*